| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 07/17/2013 | EP2614832A1 Diagnosis and treatment of preeclampsia |
| 07/17/2013 | EP2614831A1 Adiponectin for treating pulmonary disease |
| 07/17/2013 | EP2614827A2 Means and methods for counteracting muscle disorders |
| 07/17/2013 | EP2614709A1 Small animal model for HCV replication |
| 07/17/2013 | EP2614369A2 Inhibitors of human ezh2, and methods of use thereof |
| 07/17/2013 | EP2614146A1 Ttll4 peptides and vaccines containing the same |
| 07/17/2013 | EP2614080A1 Phosphorylated twist1 and metastasis |
| 07/17/2013 | EP2614078A1 Stem cell culture media and methods |
| 07/17/2013 | EP2614076A1 Modified relaxin polypeptides |
| 07/17/2013 | EP2614075A1 Single chain relaxin polypeptides |
| 07/17/2013 | EP2613800A1 Maturation of gastrointestinal tract |
| 07/17/2013 | EP2613799A1 Readthrough acetylcholinesterase (ache-r) for treating or preventing parkinson's disease |
| 07/17/2013 | EP2613798A1 Use of lysosomal acid lipase for treating lysosomal acid lipase deficiency in patients |
| 07/17/2013 | EP2613797A1 Compositions and methods for the removal of biofilms |
| 07/17/2013 | EP2613796A2 Compounds and methods |
| 07/17/2013 | EP2613795A2 Treatment of diseases |
| 07/17/2013 | EP2613794A1 Treatment of constipation-predominant irritable bowel syndrome |
| 07/17/2013 | EP2613774A2 Novel use |
| 07/17/2013 | EP2613636A1 Dietary supplement and methods of use thereof |
| 07/17/2013 | EP2261380B1 Method of preventing virus:cell fusion by inhibiting the function of the fusion initiation region in rna viruses having class I membrane fusogenic envelope proteins |
| 07/17/2013 | CN1674929B Use of protein kinase N beta |
| 07/17/2013 | CN1568329B Immunogenic peptide composition for the prevention and treatment of Alzheimer's disease |
| 07/17/2013 | CN103209989A Cyclic peptide compound or pharmacologically acceptable salt thereof and method for producing same |
| 07/17/2013 | CN103209704A Organic Compounds |
| 07/17/2013 | CN103209703A Macrocyclic proline derived hcv serine protease inhibitors |
| 07/17/2013 | CN103209702A Anticancer composition containing GKN 1 |
| 07/17/2013 | CN103209701A Immunogenic vaccine |
| 07/17/2013 | CN103209700A Broad spectrum antibiotic Arylomycin analogs |
| 07/17/2013 | CN103209699A Compounds that enable alternative mitochondrial electron transfer |
| 07/17/2013 | CN103209688A Particulate substances comprising ceramic particles for delivery of biomolecules |
| 07/17/2013 | CN103209681A Nanoparticle film delivery systems |
| 07/17/2013 | CN103205411A Small-molecular-weight sipunculus nudus fibrinolysin and preparation method and applications thereof |
| 07/17/2013 | CN103205410A Recombinant microplasmin, its preparation method and application |
| 07/17/2013 | CN103205407A Extended soluble ph20 polypeptides and uses thereof |
| 07/17/2013 | CN103204944A Long-acting immune fusion protein for treating diabetes mellitus |
| 07/17/2013 | CN103204921A Secretory protein with chemotactic activity, and coding sequence and application thereof |
| 07/17/2013 | CN103204920A Novel epidermal growth factors and applications for same |
| 07/17/2013 | CN103204910A Cyclized peptide and preparation method thereof |
| 07/17/2013 | CN103204909A Antihypertensive active peptide VPPIPP (valine-proline-proline-isoleucine-proline-proline) |
| 07/17/2013 | CN103204907A Raja porosa cartilage polypeptide angiogenesis inhibitory factor, and preparation method and application thereof |
| 07/17/2013 | CN103204904A Dasyatis akajei chondroprotein polypeptide capable of resisting prostate cancer, and preparation method and application thereof |
| 07/17/2013 | CN103204903A Hepatitis c inhibitor compounds |
| 07/17/2013 | CN103204901A Preparation method for bifunctional conjugate |
| 07/17/2013 | CN103203025A Application of gene modified mesenchymal stem cell in pulmonary fibrosis treatment |
| 07/17/2013 | CN103203023A Pdgf Amphiphilic Polymer Complex |
| 07/17/2013 | CN103203021A Hair pilatory and preparation method thereof |
| 07/17/2013 | CN103203019A Multiple-variable Dose Regimen For Treating Tnfalpha-related Disorders |
| 07/17/2013 | CN103203015A Composition containing metal beta-lactamase and preparation thereof |
| 07/17/2013 | CN103203014A Preparation method of blended functional surgical irrigating fluid |
| 07/17/2013 | CN103203013A Methods And Compositions For Oxygen Transport Comprising A High Oyzgen Affinity |
| 07/17/2013 | CN103203012A Joint health care product |
| 07/17/2013 | CN103203011A Chewing gum for preventing and treating oral ulcer after chemotherapy |
| 07/17/2013 | CN103203010A Pharmaceutical Compositions Comprising Hepatitis C Inhibitor Compounds |
| 07/17/2013 | CN103203009A New application of partial metabolite of pentapeptide in preparation of myocardial ischemia resistant product |
| 07/17/2013 | CN103203008A Pharmaceutical composition for sobering up and preparation method thereof |
| 07/17/2013 | CN103202857A Perivascular Mesenchymal Precursor Cell Induced Blood Vessel Formation |
| 07/17/2013 | CN102743568B Traditional Chinese medicine composite for treating acute gangrenous stomatitis |
| 07/17/2013 | CN102698244B Drug composition used for preventing piglets from diarrhea and promoting piglets to grow |
| 07/17/2013 | CN102603882B Antifungal peptide as well as preparation method and application thereof |
| 07/17/2013 | CN102558340B Glucagon-like peptide (GLP)-1 derivative |
| 07/17/2013 | CN102558339B GLP-1(Glucagon-like Peptide 1) derivative |
| 07/17/2013 | CN102558297B Endomorphin-1 analogue modified by alpha-alkenyl-beta-amino acid and composition and application thereof |
| 07/17/2013 | CN102532300B Interferon alpha mutant and polyethylene glycol derivative thereof |
| 07/17/2013 | CN102532299B Interferon alpha mutant and polyethylene glycol derivative thereof |
| 07/17/2013 | CN102462668B Hydrochloric acid boningmycin solid preparation and preparation method thereof |
| 07/17/2013 | CN102391370B Antimicrobial peptides, preparation method and application thereof |
| 07/17/2013 | CN102391365B A group of new antibiotic peptides, preparation method thereof and use thereof |
| 07/17/2013 | CN102391364B New antibacterial peptides as well as preparation method and application of the same |
| 07/17/2013 | CN102210864B Formula of medicament for treating non-infectious ocular inflammations, and inhibiting corneal neovascularization and anti-rejection reaction generated after corneal transplantation |
| 07/17/2013 | CN102206276B Humanized antibodies derived from DD-3B6/22, specific for the D-dimer fragment of fibrin |
| 07/17/2013 | CN102144974B Liposome preparation for anticoagulant thrombolytic difunctional fusion protein and preparation method thereof |
| 07/17/2013 | CN102120781B Preparation and application of novel oral insulin nanoparticles |
| 07/17/2013 | CN102114240B Application of medicament containing hirudin and cellosolve |
| 07/17/2013 | CN102085359B Medical composition containing hirudin and hementerin and application thereof |
| 07/17/2013 | CN102020699B Anti-platelet aggregation peptide and application thereof |
| 07/17/2013 | CN101928329B Tripeptide boric acid (ester) compound and preparation method and application thereof |
| 07/17/2013 | CN101921330B Recombinant human interferon alpha 1b mutant and preparation method thereof |
| 07/17/2013 | CN101914150B Polypeptide and use thereof in medicament preparation |
| 07/17/2013 | CN101862444B Application of interleukin 2 in preparing preparation for resisting prawn white spot syndrome virus |
| 07/17/2013 | CN101848702B Amphiphilic entity nanoparticles |
| 07/17/2013 | CN101824455B Soy protein oligopeptide, and preparation method and use thereof |
| 07/17/2013 | CN101679495B Short bio-active peptides for cellular and immunological modulation |
| 07/17/2013 | CN101677947B Pharmaceutical formulation comprising an insulin derivative |
| 07/17/2013 | CN101575361B Novel specific polypeptide and application thereof in preparing medicament for diagnosing, preventing and treating severe acute respiratory syndrome caused by coronaviruses |
| 07/17/2013 | CN101573446B Aptamer against midkine and use thereof |
| 07/17/2013 | CN101534848B Antiviral agent against animal viruses |
| 07/17/2013 | CN101522708B Peptides having activities of epidermal growth factor and its uses |
| 07/17/2013 | CN101502642B Use of hepatitis B virus x protein and encoding gene thereof in preparing medicament for treating cancer of liver |
| 07/17/2013 | CN101472943B SPARC-derived cancer rejection antigen peptide and pharmaceutical comprising the same |
| 07/17/2013 | CN101397564B Protection against environmental toxicity through manipulation of the processing of messenger RNA precursors |
| 07/17/2013 | CN101389648B Oxyntomodulin derivatives |
| 07/17/2013 | CN101365783B Production of glycoproteins with reduced o-glycosylation |
| 07/17/2013 | CN101312660B High-potency sweetener for weight management and compositions sweetened therewith |
| 07/17/2013 | CN101160123B Combinations of therapeutic agents |
| 07/17/2013 | CN101107361B Recombinant expression of proteins in a disulfide-bridged, two-chain form |
| 07/16/2013 | US8487080 Fluorine-labeled compounds |
| 07/16/2013 | US8487076 HLA-binding peptide, and DNA fragment and recombinant vector coding for said HLA-binding peptide |
| 07/16/2013 | US8487075 Alpha-conotoxin peptides |
| 07/16/2013 | US8487073 Melanocortin receptor-specific peptides for treatment of sexual dysfunction |
| 07/16/2013 | US8487072 Compounds for stimulating P-glycoprotein function and uses thereof |